Latest News about GSK
Recent news which mentions GSK
3 Pharmaceutical Stocks With Awesome Futures
April 09, 2022
From Motley Fool
3 Things About Pfizer That Smart Investors Know
April 08, 2022
From Motley Fool
From Benzinga
From Benzinga
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
April 06, 2022
From MarketWatch
3 CEOs to Invest In
April 01, 2022
From Motley Fool
Why Shares of Vir Biotechnology Rose 20.4% This Week
April 01, 2022
From Motley Fool
From Benzinga
From Benzinga
WHO urges countries to keep up COVID-19 testing and surveillance as the virus is still a global pandemic
March 30, 2022
From MarketWatch
From Benzinga
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
March 30, 2022
From Benzinga
FDA Approves ViiV Healthcare's Cabenuva For Virologically Suppressed Adolescents With HIV
March 29, 2022
From Benzinga
From Benzinga
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant
March 28, 2022
From Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
From InvestorPlace
Are These 2 Rivals Beating Pfizer and Moderna?
March 28, 2022
From Motley Fool
From Motley Fool
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022
March 25, 2022
From Motley Fool
From Benzinga
Where to Invest $100 Right Now
March 25, 2022
From Motley Fool
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
March 24, 2022
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market
March 21, 2022
From Benzinga
Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC
March 21, 2022
From Benzinga
WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC
March 16, 2022
From Benzinga
Ideaya Biosciences' IDE397 Shows Preliminary Tolerability In Early-Stage Solid Tumor Trial
March 15, 2022
From Benzinga
GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows
March 11, 2022
From Benzinga
7 Drug Stocks To Consider After the Viatris Plunge
March 10, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.